See also this year's filing and all EDGAR filings for this company.
PDF Report 0001853816_2022_Dermata_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001853816', 'EntityCommonStockSharesOutstanding': 12102214, 'Assets': 6944488, 'AssetsCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 922634, 'LiabilitiesAndStockholdersEquity': 6944488, 'LiabilitiesCurrent': 496702, 'LiabilitiesNoncurrent': 0, 'NetIncome': -9610913, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 6944488, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 425932, 'remainder_LiabilitiesAndStockholdersEquity': 6021854, 'remainder_NetIncome': -9610913, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001853816, Dermata Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,623,940 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,516,836 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 45,613 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,856,864 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,623,940 |
| 1 | Liabilities | 1,516,836 |
| 2 | Expenses | 45,613 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,107,104 |
| 5 | NetIncome | -7,902,477 |
| 6 | ComprehensiveNetIncome | -7,902,477 |
| 7 | BaseVar | 10,521,626 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.15 |
| 9 | EconomicCapitalRatio | 3.12 |